{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,8]],"date-time":"2026-09-08T21:37:25Z","timestamp":1788903445587,"version":"build-2803163510"},"reference-count":13,"publisher":"Springer Science and Business Media LLC","issue":"9","license":[{"start":{"date-parts":[[2010,3,30]],"date-time":"2010-03-30T00:00:00Z","timestamp":1269907200000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Br J Cancer"],"published-print":{"date-parts":[[2010,4]]},"DOI":"10.1038\/sj.bjc.6605619","type":"journal-article","created":{"date-parts":[[2010,3,30]],"date-time":"2010-03-30T20:04:19Z","timestamp":1269979459000},"page":"1405-1410","source":"Crossref","is-referenced-by-count":43,"title":["Long-term follow-up of cervical disease in women screened by cytology and HPV testing: results from the HART study"],"prefix":"10.1038","volume":"102","author":[{"given":"D","family":"Mesher","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"A","family":"Szarewski","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"L","family":"Cadman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"H","family":"Cubie","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"H","family":"Kitchener","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"D","family":"Luesley","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"U","family":"Menon","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"G","family":"Hulman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M","family":"Desai","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"L","family":"Ho","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"G","family":"Terry","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"A","family":"Williams","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"P","family":"Sasieni","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"J","family":"Cuzick","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2010,3,30]]},"reference":[{"key":"BF6605619_CR1","doi-asserted-by":"publisher","first-page":"677","DOI":"10.1158\/1055-9965.EPI-04-0569","volume":"14","author":"F Bray","year":"2005","unstructured":"Bray F, Loos AH, McCarron P, Weiderpass E, Arbyn M, Moller H, Hakama M, Parkin DM (2005) Trends in cervical squamous cell carcinoma incidence in 13 European countries: changing risk and the effects of screening. Cancer Epidemiol Biomarkers Prev 14: 677\u2013686","journal-title":"Cancer Epidemiol Biomarkers Prev"},{"key":"BF6605619_CR2","doi-asserted-by":"publisher","first-page":"1764","DOI":"10.1016\/S0140-6736(07)61450-0","volume":"370","author":"NW Bulkmans","year":"2007","unstructured":"Bulkmans NW, Berkhof J, Rozendaal L, van Kemenade FJ, Boeke AJ, Bulk S, Voorhorst FJ, Verheijen RH, van Groningen K, Boon ME, Ruitinga W, van Ballegooijen M, Snijders PJ, Meijer CJ (2007) Human papillomavirus DNA testing for the detection of cervical intraepithelial neoplasia grade 3 and cancer: 5-year follow-up of a randomised controlled implementation trial. Lancet 370: 1764\u20131772","journal-title":"Lancet"},{"issue":"Suppl 3","key":"BF6605619_CR3","first-page":"S3\/26","volume":"24","author":"G Clifford","year":"2006","unstructured":"Clifford G, Franceschi S, Diaz M, Munoz N, Villa LL (2006) Chapter 3: HPV type-distribution in women with and without cervical neoplastic diseases. Vaccine 24 (Suppl 3): S3\/26\u2013S3\/34","journal-title":"Vaccine"},{"key":"BF6605619_CR4","doi-asserted-by":"publisher","first-page":"1095","DOI":"10.1002\/ijc.21955","volume":"119","author":"J Cuzick","year":"2006","unstructured":"Cuzick J, Clavel C, Petry KU, Meijer CJ, Hoyer H, Ratnam S, Szarewski A, Birembaut P, Kulasingam S, Sasieni P, Iftner T (2006) Overview of the European and North American studies on HPV testing in primary cervical cancer screening. Int J Cancer 119: 1095\u20131101","journal-title":"Int J Cancer"},{"key":"BF6605619_CR5","doi-asserted-by":"publisher","first-page":"1871","DOI":"10.1016\/S0140-6736(03)14955-0","volume":"362","author":"J Cuzick","year":"2003","unstructured":"Cuzick J, Szarewski A, Cubie H, Hulman G, Kitchener H, Luesley D, McGoogan E, Menon U, Terry G, Edwards R, Brooks C, Desai M, Gie C, Ho L, Jacobs I, Pickles C, Sasieni P (2003) Management of women who test positive for high-risk types of human papillomavirus: the HART study. Lancet 362: 1871\u20131876","journal-title":"Lancet"},{"key":"BF6605619_CR6","doi-asserted-by":"publisher","first-page":"2294","DOI":"10.1002\/ijc.23339","volume":"122","author":"J Cuzick","year":"2008","unstructured":"Cuzick J, Szarewski A, Mesher D, Cadman L, Austin J, Perryman K, Ho L, Terry G, Sasieni P, Dina R, Soutter WP (2008) Long-term follow-up of cervical abnormalities among women screened by HPV testing and cytology \u2013 results from the Hammersmith study. Int J Cancer 122: 2294\u20132300","journal-title":"Int J Cancer"},{"key":"BF6605619_CR7","doi-asserted-by":"publisher","first-page":"a1754","DOI":"10.1136\/bmj.a1754","volume":"337","author":"J Dillner","year":"2008","unstructured":"Dillner J, Rebolj M, Birembaut P, Petry KU, Szarewski A, Munk C, de Sanjose S, Naucler P, Lloveras B, Kjaer S, Cuzick J, van Ballegooijen M, Clavel C, Iftner T (2008) Long term predictive values of cytology and human papillomavirus testing in cervical cancer screening: joint European cohort study. BMJ 337: a1754","journal-title":"BMJ"},{"key":"BF6605619_CR8","doi-asserted-by":"publisher","first-page":"1247","DOI":"10.1016\/S0140-6736(87)92695-X","volume":"1","author":"E Laara","year":"1987","unstructured":"Laara E, Day NE, Hakama M (1987) Trends in mortality from cervical cancer in the Nordic countries: association with organised screening programmes. Lancet 1: 1247\u20131249","journal-title":"Lancet"},{"issue":"23","key":"BF6605619_CR9","doi-asserted-by":"publisher","first-page":"1612","DOI":"10.1093\/jnci\/djp367","volume":"101","author":"M Leinonen","year":"2009","unstructured":"Leinonen M, Nieminen P, Kotaniemi-Talonen L, Malila N, Tarkkanen J, Laurila P, Anttila A (2009) Age-specific evaluation of primary human papillomavirus screening vs conventional cytology in a randomized setting. J Natl Cancer Inst 101 (23): 1612\u20131623","journal-title":"J Natl Cancer Inst"},{"issue":"3","key":"BF6605619_CR10","doi-asserted-by":"publisher","first-page":"249","DOI":"10.1016\/S1470-2045(09)70360-2","volume":"11","author":"G Ronco","year":"2010","unstructured":"Ronco G, Giorgi-Rossi P, Carozzi F, Confortini M, Palma PD, Del Mistro A, Ghiringhello B, Girlando S, Gillio-Tos A, De Marco L, Naldoni C, Pierotti P, Rizzolo R, Schincaglia P, Zorzi M, Zappa M, Segnan N, Cuzick J (2010) Efficacy of human papillomavirus testing for the detection of invasive cervical cancers and cervical intraepithelial neoplasia: a randomised controlled trial. Lancet Oncol 11 (3): 249\u2013257","journal-title":"Lancet Oncol"},{"key":"BF6605619_CR11","doi-asserted-by":"publisher","first-page":"88","DOI":"10.1038\/sj.bjc.6600974","volume":"89","author":"P Sasieni","year":"2003","unstructured":"Sasieni P, Adams J, Cuzick J (2003) Benefit of cervical screening at different ages: evidence from the UK audit of screening histories. Br J Cancer 89: 88\u201393","journal-title":"Br J Cancer"},{"key":"BF6605619_CR12","doi-asserted-by":"publisher","first-page":"49","DOI":"10.1136\/jms.9.2.49","volume":"9","author":"P Sasieni","year":"2002","unstructured":"Sasieni P, Cuzick J (2002) Could HPV testing become the sole primary cervical screening test? J Med Screen 9: 49\u201351","journal-title":"J Med Screen"},{"key":"BF6605619_CR13","doi-asserted-by":"publisher","first-page":"1854","DOI":"10.1002\/ijc.23276","volume":"122","author":"MA van der Aa","year":"2008","unstructured":"van der Aa MA, Pukkala E, Coebergh JW, Anttila A, Siesling S (2008) Mass screening programmes and trends in cervical cancer in Finland and the Netherlands. Int J Cancer 122: 1854\u20131858","journal-title":"Int J Cancer"}],"container-title":["British Journal of Cancer"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/www.nature.com\/articles\/6605619.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/www.nature.com\/articles\/6605619","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/www.nature.com\/articles\/6605619.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,5,18]],"date-time":"2023-05-18T12:44:43Z","timestamp":1684413883000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/6605619"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2010,3,30]]},"references-count":13,"journal-issue":{"issue":"9","published-print":{"date-parts":[[2010,4]]}},"alternative-id":["BF6605619"],"URL":"https:\/\/doi.org\/10.1038\/sj.bjc.6605619","relation":{},"ISSN":["0007-0920","1532-1827"],"issn-type":[{"value":"0007-0920","type":"print"},{"value":"1532-1827","type":"electronic"}],"subject":[],"published":{"date-parts":[[2010,3,30]]}}}